Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
For more details on financing and valuation for Respicardia, register or login.
Respicardia does not have a ticker symbol because this company got acquired.
The stock price for Respicardia will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
To read this article and more news on Respicardia, register or login.